- Docket No.
- 23-40605
- Appellate Court
- Fifth Circuit
Goal
- Invalidate all or part of a federal regulation
Issues
Case History
Litigation Content
Why this Matters
The plaintiffs argue that regulations outlining the methodology used to calculate the No Surprises Act’s qualifying payment amount (the basis for determining individual cost sharing for items and services covered by the balance-billing protections) are invalid under the Administrative Procedure Act. The design of the qualifying payment amount is critical to the No Surprises Act’s mission to promote lower health care premiums and costs, both for consumers directly for out-of-network services as well as through the arbitration process.
Potential Impact
Setting aside the methodology to calculate the qualifying payment amount for health care services in virtually all settings could expose patients to higher cost sharing and make the arbitration process more likely to raise health care costs and premiums.
21 Major Filings
- JUDGMENT (Oct 30, 2024)
- OPINION (Oct 30, 2024)
- ORAL ARGUMENT HEARD (Sep 3, 2024)
- RESPONSE TO NOTICE OF SUPPLEMENTAL AUTHORITIES (Aug 8, 2024)
- NOTICE OF SUPPLEMENTAL AUTHORITIES (Aug 6, 2024)
- NOTICE OF SUPPLEMENTAL AUTHORITIES (Jul 8, 2024)
- RESPONSE TO NOTICE OF SUPPLEMENTAL AUTHORITIES (Jul 8, 2024)
- NOTICE OF SUPPLEMENTAL AUTHORITIES (Jul 3, 2024)
- REPLY BRIEF OF APPELLEES/CROSS-APPELLANTS (Jun 3, 2024)
- RESPONSE AND REPLY BRIEF FOR APPELLANTS (May 13, 2024)
- AMICUS BRIEF (Emergency Department Practice Management Association) (Mar 20, 2024)
- AMICUS BRIEF (Physicians Advocacy Institute et al.) (Mar 20, 2024)
- AMICUS BRIEF (American Society of Anesthesiologists et al.) (Mar 20, 2024)
- AMICUS BRIEF (AMA) (Mar 20, 2024)
- CROSS APPELLANT'S BRIEF (East Texas Air One et al.) (Mar 13, 2024)
- CROSS APPELLANT'S BRIEF (Texas Medical Association et al.) (Mar 13, 2024)
- AMICUS BRIEF (Leukemia & Lymphoma Society et al.) (Jan 19, 2024)
- AMICUS BRIEF (BCBSA) (Jan 19, 2024)
- AMICUS BRIEF (AHIP) (Jan 19, 2024)
- BRIEF FOR APPELLANTS (Jan 12, 2024)
- NOTICE OF CROSS-APPEAL (Oct 31, 2023)